Vanguard Personalized Indexing Management, LLC Biomarin Pharmaceutical Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 13,993 shares of BMRN stock, worth $726,376. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,993
Previous 24,426
42.71%
Holding current value
$726,376
Previous $1.73 Million
55.45%
% of portfolio
0.01%
Previous 0.03%
Shares
17 transactions
Others Institutions Holding BMRN
# of Institutions
693Shares Held
187MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.18 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$986 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$819 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$784 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$638 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.65B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...